Connection
Anne Lynch to Disease Progression
This is a "connection" page, showing publications Anne Lynch has written about Disease Progression.
|
|
Connection Strength |
|
 |
|
 |
|
0.211 |
|
|
|
-
Patnaik JL, Stutzman J, Mehner L, McCourt E, Lynch AM. Characteristics of babies with unstable clinical course screened for retinopathy of prematurity. J AAPOS. 2023 Feb; 27(1):37-39.
Score: 0.118
-
Gnanaraj R, Lisker-Cervantes A, Patnaik J, Rajeswaren V, Mehta N, Gange W, Lynch AM, Palestine A, Mathias M, Manoharan N, Mandava N, Forest TEC. Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry. BMJ Open Ophthalmol. 2025 Apr 05; 10(1).
Score: 0.035
-
de Carlo Forest TE, Gill Z, Lisker-Cervantes A, Gnanaraj R, Grove N, Patnaik JL, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N. Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate. Am J Ophthalmol. 2024 08; 264:168-177.
Score: 0.032
-
Hoffman MC, Rumer KK, Kramer A, Lynch AM, Winn VD. Maternal and fetal alternative complement pathway activation in early severe preeclampsia. Am J Reprod Immunol. 2014 Jan; 71(1):55-60.
Score: 0.016
-
Best AC, Meng J, Lynch AM, Bozic CM, Miller D, Grunwald GK, Lynch DA. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology. 2008 Mar; 246(3):935-40.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|